Moderna | MRNA - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Celltrion KRW 56.79B 6.92B 2026-03
Cspc Pharmaceutical CNY 6.09B 1.48B 2025-12
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 110.55M 517.12M 2026-06
Divis Laboratories Ltd INR 1.28B 2.87B 2026-03
Gilead Sciences USD 7.63B 64M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 3.98B 33.45M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Moderna USD 1.72B 185M 2026-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pharma Mar EUR 19.34M 29.53M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Qiagen NV USD 646.29M 192.72M 2026-03
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
United Therapeutics USD 1.8B 523.5M 2026-06
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06
Zealand Pharma A/S 3.85B 727.54M 2026-03
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03